Table of Contents Author Guidelines Submit a Manuscript
Letter to the Editor
Clinical Study
Journal of Immunology Research
Volume 2018, Article ID 6156024, 3 pages
https://doi.org/10.1155/2018/6156024
Letter to the Editor

Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”

Unidad de Investigación y Desarrollo, Probiomed S.A. de C.V., Cruce de Carreteras Acatzingo-Zumpahuacán S/N, Colonia Los Shiperes, 52400 Tenancingo de Degollado, MEX, Mexico

Correspondence should be addressed to Luis F. Flores-Ortiz; moc.liamg@zitroserolfocfsiul

Received 9 July 2017; Accepted 15 October 2017; Published 21 February 2018

Academic Editor: Ethan M. Shevach

Copyright © 2018 Mariana P. Miranda-Hernández et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Hassett, S. Vicik, and B. Fitzpatrick, “Comment on “New alternatives for autoimmune disease treatments: physicochemical and clinical comparability of biosimilar etanercept”,” Journal of Immunology Research, vol. 2018, Article ID 5047067, 3 pages, 2018. View at Publisher · View at Google Scholar
  2. M. P. Miranda-Hernández, C. A. López-Morales, F. C. Perdomo-Abúndez et al., “New alternatives for autoimmune disease treatments: physicochemical and clinical comparability of biosimilar etanercept,” Journal of Immunology Research, vol. 2016, Article ID 9697080, 9 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Houel, M. Hilliard, Y. Q. Yu et al., “N- and O-glycosylation analysis of etanercept using liquid, chromatography and quadrupole time-of-flight mass spectrometry equipped with electron-transfer dissociation functionality,” Analytical Chemistry, vol. 86, p. 576, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Piña-Lara, L. C. Juárez-Bayardo, A. V. Hernández-García et al., Characterization and Comparability of Etanercept Biosimilar, World Biosimilar Congress, Geneva, Switzerland, 2013.
  5. M. Schiestl, T. Stangler, C. Torella, T. Cepeljnik, H. Toll, and R. Grau, “Acceptable changes in quality attributes of glycosylated biopharmaceuticals,” Nature Biotechnology, vol. 29, p. 301, 2011. View at Publisher · View at Google Scholar · View at Scopus